55 related articles for article (PubMed ID: 38436282)
1. MERTK in the rat trigeminal system: a potential novel target for cluster headache?
Edvinsson JCA; Ran C; Olofsgård FJ; Steinberg A; Edvinsson L; Belin AC
J Headache Pain; 2024 May; 25(1):85. PubMed ID: 38783191
[TBL] [Abstract][Full Text] [Related]
2. Effect of Infusion of Calcitonin Gene-Related Peptide on Cluster Headache Attacks: A Randomized Clinical Trial.
Vollesen ALH; Snoer A; Beske RP; Guo S; Hoffmann J; Jensen RH; Ashina M
JAMA Neurol; 2018 Oct; 75(10):1187-1197. PubMed ID: 29987329
[TBL] [Abstract][Full Text] [Related]
3. Calcitonin-gene related peptide and disease activity in cluster headache.
Snoer A; Vollesen ALH; Beske RP; Guo S; Hoffmann J; Fahrenkrug J; Jørgensen NR; Martinussen T; Jensen RH; Ashina M
Cephalalgia; 2019 Apr; 39(5):575-584. PubMed ID: 30854880
[TBL] [Abstract][Full Text] [Related]
4. S100B and NSE in Cluster Headache - Evidence for Glial Cell Activation?
Snoer AH; Vollesen ALH; Beske RP; Guo S; Hoffmann J; Jørgensen NR; Martinussen T; Ashina M; Jensen RH
Headache; 2020 Sep; 60(8):1569-1580. PubMed ID: 32548854
[TBL] [Abstract][Full Text] [Related]
5. Increase in plasma calcitonin gene-related peptide from the extracerebral circulation during nitroglycerin-induced cluster headache attack.
Fanciullacci M; Alessandri M; Figini M; Geppetti P; Michelacci S
Pain; 1995 Feb; 60(2):119-123. PubMed ID: 7540279
[TBL] [Abstract][Full Text] [Related]
6. Reduced plasma calcitonin gene-related peptide level identified in cluster headache: A prospective and controlled study.
Petersen AS; Lund N; Meßlinger K; Christensen SL; Barloese M; Jørgensen NR; Kogelman L; Jensen RH
Cephalalgia; 2024 Mar; 44(3):3331024231223970. PubMed ID: 38436282
[TBL] [Abstract][Full Text] [Related]
7. Calcitonin gene-related peptide antagonism and cluster headache: an emerging new treatment.
Ashina H; Newman L; Ashina S
Neurol Sci; 2017 Dec; 38(12):2089-2093. PubMed ID: 28856479
[TBL] [Abstract][Full Text] [Related]
8. Anti-CGRP in cluster headache therapy.
Giani L; Proietti Cecchini A; Leone M
Neurol Sci; 2019 May; 40(Suppl 1):129-135. PubMed ID: 30820761
[TBL] [Abstract][Full Text] [Related]
9. CGRP-Targeted Therapy for Episodic and Chronic Cluster Headache.
Chen ST; Wu JW
Curr Pain Headache Rep; 2022 Sep; 26(9):667-675. PubMed ID: 35881279
[TBL] [Abstract][Full Text] [Related]
10. Effects of acute and preventive therapies for episodic and chronic cluster headache: A scoping review of the literature.
Medrea I; Christie S; Tepper SJ; Thavorn K; Hutton B
Headache; 2022 Mar; 62(3):329-362. PubMed ID: 35315067
[TBL] [Abstract][Full Text] [Related]
11. The role of anti-CGRP antibodies in the pathophysiology of primary headaches.
Barbanti P; Aurilia C; Fofi L; Egeo G; Ferroni P
Neurol Sci; 2017 May; 38(Suppl 1):31-35. PubMed ID: 28527063
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]